Evidence map›Paper›PMID 41685752›Full record

ArticleJournal of developmental and behavioral pediatrics : JDBP

Complex Attention-Deficit Hyperactivity Disorder in a 15-year-old With a Substance Use Disorder.

Kevin M Simon, Modar Sukkarieh, Emmett Walsh, Leslie Green, Laurie A Gates, Elizabeth A Diekroger, Jason M Fogler

Abstract readCase Reports
In one paragraph

Article in Journal of developmental and behavioral pediatrics : JDBP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kevin M SimonDivision of Addiction Medicine, Boston Children's Hospital, Boston, MA.
Modar SukkariehDivision of Addiction Medicine, Boston Children's Hospital, Boston, MA.
Emmett WalshDivision of Addiction Medicine, Boston Children's Hospital, Boston, MA.
Leslie GreenDivision of Addiction Medicine, Boston Children's Hospital, Boston, MA.
Laurie A GatesDivision of Addiction Medicine, Boston Children's Hospital, Boston, MA.
Elizabeth A DiekrogerUH Rainbow Babies and Children's Hospital, Cleveland, OH.
Jason M FoglerHarvard Medical School, Boston, MA.ORCID 0000-0002-5566-8783

Funding

AACAP Physician Scientist Program in Substance UseK12DA000357 · NIDA · AMERICAN ACADEMY-CHILD/ADOLESCENT PSYCH · PI Kevin M. Gray · 1998 to 2026
$29.1M
NIDA NIH HHS K12 DA000357
6 · The paper itself

Abstract

case"JD" (identifying details have been changed), a 15-year-old Afro-Caribbean female sophomore student diagnosed with attention-deficit hyperactivity disorder (ADHD), was referred to an Adolescent Substance Use and Addiction Program after substance use disorder screening indicated a positive result, suggesting significant risk. The screening was part of a routine checkup by her primary care provider after noticeable declines in her academic performance and mood.Previously a consistent student, JD's struggles with inattention, forgetfulness, and organizational challenges had become increasingly apparent. Teachers reported that JD seemed perpetually distracted, disengaged, and frequently excused herself to the bathroom. "It's like I'm there, but not really there," JD explained during an evaluation, describing how disconnected she felt from her surroundings. Moreover, her involvement in extracurricular activities such as the debate club and soccer had waned, changes she vaguely attributed to "lack of energy." JD's mother described the transformation as watching her daughter "slip away into someone unrecognizable. Every day brings a new worry."At home, JD's mother discovered JD vaping and found what appeared to be drug paraphernalia in her backpack. Distraught, she confided the ongoing strain these discoveries placed on the family. This period marked a significant emotional toll on the family, accentuating the urgent need for intervention. The sense of loss felt by JD's family was compounded by their fear of her potential decline into more dangerous behaviors, especially given that JD's maternal uncle died of an unintentional opioid-involved overdose.In the initial consultation, JD was reticent to talk about her substance use but gradually disclosed her regular use of cannabis and nicotine via vaping. JD explained that nicotine temporarily enhanced her focus, whereas cannabis provided relief from overwhelming stress, albeit occasionally accompanied by episodes of paranoia. "Sometimes it feels like it's the only thing that calms things down in my head," JD admitted. She voiced a readiness to quit nicotine but showed ambivalence about changing her cannabis use. Despite the adverse effects, JD perceived these substances as benign when compared with other drugs or alcohol ("weed is natural").Complicating the clinical picture, JD viewed her friends as support pillars, contrary to her parents' beliefs that these relationships exacerbated her substance use. Her parents advocated for a strict regimen of abstinence from all substances and a complete disassociation from her friends. "They think my friends are the problem, but they're not," JD contested.The cultural dimensions of JD's identity significantly influenced her engagement with treatment. JD articulated her desire for a treatment approach that respected her and asked for a clinician who could "see where I'm coming from… someone who understands me, not someone who just wants to change me."Considering JD's ADHD diagnosis, her escalating substance use, and the socio-cultural factors influencing her behavior, what approaches could best address the interplay of these elements to foster a holistic and effective treatment plan for her?

Indexed as

Attention Deficit Disorder with HyperactivitySubstance-Related DisordersAdolescentFemaleHumansADHDbehavioral health disparitiescomplex ADHDintegrated caresubstance use disorder (SUD)

Identifiers

PMID41685752
PMCPMC12904219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.